AlloMek Therapeutics
Woodbridge, US · Delaware LLC
Founders & leadership
JF
Jason FishermanNamed on SEC filing
DW
Daniel WagnerNamed on SEC filing
UK
Uday KhireNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 round · 2016
▶$1.3MraisedFeb 2020 · 1 investors · BiotechnologyRule 506(b)
▶$1.3MraisedFeb 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jason FishermanDirector
- Daniel WagnerDirector
- Uday KhireExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Dec 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has AlloMek Therapeutics raised?
- AlloMek Therapeutics has disclosed $1.3M raised across 1 round.
- Where is AlloMek Therapeutics headquartered?
- AlloMek Therapeutics is headquartered in Woodbridge, US.